Alpa Laboratories Ltd.
| BSE: 532878 | Sector: Health care |
| NSE: ALPA | ISIN Code: INE385I01010 |
| BSE 00:00 | 20 Sep | 52.25 |
-0.70 (-1.32%) |
OPEN
51.90 |
HIGH
53.25 |
LOW
51.90 |
| NSE 00:00 | 20 Sep | 52.15 |
-0.85 (-1.60%) |
OPEN
53.00 |
HIGH
53.50 |
LOW
52.00 |
| OPEN | 51.90 |
| PREVIOUS CLOSE | 52.95 |
| VOLUME | 4661 |
| 52-Week high | 73.15 |
| 52-Week low | 26.15 |
| P/E | 10.49 |
| Mkt Cap.(Rs cr) | 110 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alpa Laboratories Ltd. (ALPA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 712.45 | -33.35 | -4.47 | 3112.91 |
| Cipla | 939.05 | -15.10 | -1.58 | 2468.28 |
| Dr Reddy's Labs | 4776.50 | -112.65 | -2.30 | 2186.40 |
| Sun Pharma.Inds. | 756.55 | -13.70 | -1.78 | 2139.70 |
| Divi's Lab. | 5108.60 | -17.05 | -0.33 | 1954.72 |
| Alkem Lab | 3786.55 | -47.00 | -1.23 | 1685.08 |
| Glenmark Pharma. | 494.95 | -24.30 | -4.68 | 1649.45 |
| Cadila Health. | 546.35 | -11.60 | -2.08 | 1476.20 |
| Lupin | 933.40 | -17.30 | -1.82 | 1258.62 |
| Alembic Pharma | 783.50 | 6.65 | 0.86 | 1175.39 |
| Ipca Labs. | 2412.45 | -83.70 | -3.35 | 1140.77 |
| Torrent Pharma. | 3049.00 | -47.45 | -1.53 | 1137.85 |
| Gland Pharma | 3899.50 | -73.95 | -1.86 | 997.01 |
| Laurus Labs | 633.50 | -17.70 | -2.72 | 956.11 |
| Abbott India | 20545.90 | 53.65 | 0.26 | 690.69 |
| Ajanta Pharma | 2218.60 | 32.50 | 1.49 | 675.64 |
| Wockhardt | 431.40 | -8.90 | -2.02 | 593.29 |
| Granules India | 320.30 | -7.60 | -2.32 | 552.78 |
| Pfizer | 5764.15 | -109.45 | -1.86 | 497.61 |
| Sanofi India | 7826.00 | -87.90 | -1.11 | 477.60 |
Quick Links for Alpa Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
